Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912000 · ClinicalTrials.gov registry record · NA
TEACH: Technology Evaluation to Address Child Health
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 650
- Enrollment target
NCT02912000: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02912000 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 650 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912000, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
Study Summary
The proposed study is a pre- /post-implementation study in a pediatric practice with a control practice designed to test the feasibility and effectiveness of an electronic screening and service delivery tool for three modifiable health risk factors in pediatrics: parental tobacco use, sugar-sweetened beverages consumption, and poor dental care
Primary Outcome
Higher rates of screening, counseling, and service delivery by clinicians in the period after implementation than at baseline (pre-implementation).
Interventions
- BEHAVIORAL TEACH intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT02912000 record still lists
NCT02912000 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (54% lower).
The record links to 0 conditions, and to 1 intervention - of which TEACH intervention is the first listed.
NCT02912000 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02912000 about?
NCT02912000 is a clinical study titled "TEACH: Technology Evaluation to Address Child Health". The proposed study is a pre- /post-implementation study in a pediatric practice with a control practice designed to test the feasibility and effectiveness of an electronic screening and service delivery tool for three modifiable health risk factors in pediatrics: parental tobacco use, sugar-sweetene...
What is the current status of trial NCT02912000?
This trial is currently completed. It is a NA study. The enrollment target is 650 participants. The study started on 2016-09. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02912000?
The interventions under investigation include: TEACH intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02912000?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02912000's enrollment target sits among peer trials
650 156th of 2000 higher than 1,845 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia